SHANG.FOS.PHARM.GR.H YC 1

Research SHANG.FOS.PHARM.GR.H YC 1 (08HH) on Bullrun: valuation model: 34.4% undervalued, market cap EUR 4.43B, P/E 9.8, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker08HH
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Valuation signal34.4% undervalued
• Market capEUR 4.43B
• P/E9.8
• Dividend yield3.0%
• Financial periodQ1 2026
• RevenueEUR 10.07B
• Net incomeEUR 870.83M
• Free cash flowEUR 57.23M
• Gross margin49.7%

Valuation Snapshot

Bullrun's latest valuation model marks SHANG.FOS.PHARM.GR.H YC 1 as 34.4% undervalued; latest market cap is EUR 4.43B; P/E is 9.8; dividend yield is 3.0%.

About SHANG.FOS.PHARM.GR.H YC 1

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others.

Frequently asked questions

Is SHANG.FOS.PHARM.GR.H YC 1 overvalued or undervalued?

Bullrun's valuation model currently marks SHANG.FOS.PHARM.GR.H YC 1 as 34.4% undervalued.

What is SHANG.FOS.PHARM.GR.H YC 1's market cap?

SHANG.FOS.PHARM.GR.H YC 1's market capitalization is EUR 4.43B.

What is SHANG.FOS.PHARM.GR.H YC 1's P/E ratio?

SHANG.FOS.PHARM.GR.H YC 1's price-to-earnings (P/E) ratio is 9.8.

Does SHANG.FOS.PHARM.GR.H YC 1 pay a dividend?

SHANG.FOS.PHARM.GR.H YC 1 has a dividend yield of 3.0%.

What does SHANG.FOS.PHARM.GR.H YC 1 do?

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others.